| D00125 |
Etoposide (JP18/USP/INN); Vepesid (TN) |
(P) Target: TOP2A TOP2B |
| D00168 |
Cytarabine (JP18/USP/INN); ARA-C; Depocyt (TN) |
(P) unclassified |
| D00208 |
Mitomycin (USP/INN); Mitomycin C (JP18); MMC; Jelmyto (TN); Mitomycin (TN); Muamycin (TN) |
(P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(CI,P) unclassified |
| D00214 |
Dactinomycin (USP); Actinomycin D (JP18); Cosmegen (TN) |
(P) unclassified |
| D00252 |
Carbamazepine (JP18/USP/INN); Equetro (TN); Tegretol (TN) |
(P) unclassified |
| D00275 |
Cisplatin (JP18/USP/INN); Platinol (TN) |
(P) unclassified |
| D00287 |
Cyclophosphamide (USP); Cyclophosphamide hydrate (JP18); Cytoxan (TN); Neosar (TN) |
(P) unclassified |
| D00288 |
Dacarbazine (JAN/USP/INN); DTIC-Dome (TN) |
(P) unclassified |
| D00323 |
Flucytosine (JP18/USP/INN); Ancobon (TN) |
(P) unclassified |
| D00341 |
Hydroxyurea (USP); Hydroxycarbamide (JAN/INN); Droxia (TN); Hydrea (TN); Siklos (TN) |
(P) unclassified |
| D00343 |
Ifosfamide (JAN/USP/INN); Ifex (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) unclassified |
| D00491 |
Paclitaxel (JAN/USP/INN); Abraxane (TN); Taxol (TN) |
(P) unclassified |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) unclassified |
| D00584 |
Fluorouracil (JP18/USP/INN); 5-FU (TN); Adrucil (TN); Carac (TN); Fluoroplex (TN) |
(P) unclassified |
| D01059 |
Nimustine hydrochloride (JAN); Nidran (TN) |
(P) unclassified |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
| D01068 |
Vinblastine sulfate (JP18/USP); Exal (TN); Velban (TN) |
(P) unclassified |
| D01155 |
Gemcitabine hydrochloride (JAN/USP); Gemzar (TN) |
(P) unclassified |
| D01211 |
Leucovorin calcium (USP); Calcium folinate (JP18); Uzel (TN); Wellcovorin (TN) |
(P) unclassified |
| D01264 |
Daunorubicin hydrochloride (JP18/USP); Cerubidine (TN) |
(P) Target: TOP2A TOP2B |
| D01275 |
Doxorubicin hydrochloride (JP18/USP); Adriacin (TN); Adriamycin (TN); Doxil (TN); Rubex (TN) |
(P) Target: TOP2A TOP2B |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
| D01309 |
Doxifluridine (JP18/INN); Furtulon (TN) |
(P) unclassified |
| D01363 |
Carboplatin (JP18/USP/INN); Paraplatin (TN) |
(P) unclassified |
| D01404 |
Sobuzoxane (JAN); Perazolin (TN) |
(P) Target: TOP2A TOP2B |
| D01416 |
Nedaplatin (JAN/INN); Aqupla (TN) |
(P) unclassified |
| D01633 |
Enocitabine (JAN/INN); Sunrabin (TN) |
(P) unclassified |
| D01747 |
Idarubicin hydrochloride (JP18/USP); Idamycin (TN) |
(P) Target: TOP2A TOP2B |
| D01760 |
Ranimustine (JAN/INN); Cymerin (TN) |
(P) unclassified |
| D01769 |
Vindesine sulfate (JAN/USAN); Fildesin (TN) |
(P) unclassified |
| D01790 |
Oxaliplatin (JAN/USP/INN); Eloxatin (TN) |
(P) unclassified |
| D01907 |
Fludarabine phosphate (JAN/USP); Fludara (TN) |
(P) unclassified |
| D01911 |
Aclarubicin hydrochloride (JP18); Aclacinon (TN) |
(P) Target: TOP2A TOP2B |
| D01935 |
Vinorelbine tartrate (USP); Vinorelbine ditartrate (JAN); KW 2307; Navelbine (TN) |
(P) unclassified |
| D02063 |
Peplomycin sulfate (JP18/USAN); Pepleo (TN) |
(P) unclassified |
| D02126 |
Primaquine phosphate (JAN/USP); Primaquine (TN) |
(P) unclassified |
| D02131 |
Tegafur and uracil; Uftoral (TN) |
(P) unclassified |
| D02165 |
Docetaxel (USP); Docetaxel hydrate (JP18); Docetaxel trihydrate; Taxotere (TN) |
(P) unclassified |
| D02166 |
Mitoxantrone hydrochloride (JAN/USP); Novantron (TN) |
(P) Target: TOP2A TOP2B |
| D02168 |
Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN); Hycamtin (TN); Potactasol (TN) |
(P) unclassified |
| D02177 |
Bleomycin sulfate (JP18/USP); Blenoxane (TN) |
(P) unclassified |
| D02197 |
Vincristine sulfate (JP18/USP); VCR; Marqibo (TN); Oncovin (TN); Vincasar (TN); Vincrex (TN) |
(P) unclassified |
| D02200 |
Pilocarpine hydrochloride (JP18/USP); Isopto carpine (TN); Pilopine HS (TN); Salagen (TN); Sanpilo (TN) |
(P) unclassified |
| D02214 |
Epirubicin hydrochloride (JP18/USP); EPI; Ellence (TN) |
(P) Target: TOP2A TOP2B |
| D03046 |
Cytarabine ocfosfate hydrate (JAN); Cytarabine ocfosphate hydrate; Fosteabine sodium monohydrate; Starasid (TN) |
(P) unclassified |
| D03229 |
Bleomycin hydrochloride (JP18); BLM; Bleo (TN) |
(P) unclassified |
| D03230 |
Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) |
(P) unclassified |
| D03250 |
Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Lantus (TN) |
(P) unclassified |
| D03257 |
Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN); Trastuzumab-pkrb; Trastuzumab-anns; Trastuzumab-dkst; Trastuzumab-dttb; Trastuzumab-qyyp; Trastuzumab-anns; Herceptin (TN); Herzuma (TN); Kanjinti (TN); Ogivri (TN); Ontruzant (TN) |
(P) unclassified |
| D03846 |
Dimethyl fumarate (JAN/USAN); Tecfidera (TN) |
(P) unclassified |
| D04187 |
Fingolimod hydrochloride (JAN/USAN); Gilenya (TN) |
(P) unclassified |
| D04475 |
Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; NovoRapid (TN); Novolog (TN) |
(P) unclassified |
| D04477 |
Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) |
(P) unclassified |
| D04539 |
Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) |
(P) unclassified |
| D04540 |
Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) |
(P) unclassified |
| D04547 |
Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN); Humalog PEN (TN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
| D05446 |
Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN); Perjeta (TN) |
(P) unclassified |
| D05932 |
Streptozocin (JAN/USAN/INN); Streptozotocin; Zanosar (TN) |
(P) unclassified |
| D06272 |
Sorafenib tosylate (USAN); Sorafenib tosilate (JAN); Nexavar (TN) |
(P) unclassified |
| D06399 |
Tegafur, gimeracil and oteracil potassium; Ts-1 (TN); Teysuno (TN) |
(P) unclassified |
| D06503 |
Pemetrexed sodium hydrate (JAN); Pemetrexed disodium heptahydrate; Alimta (TN) |
(P) unclassified |
| D07085 |
Bendamustine hydrochloride (JAN/USAN); Treanda (TN); Ribomustin (TN) |
(P) unclassified |
| D07100 |
Amrubicin hydrochloride (JAN/USAN); Calsed (TN) |
(P) Target: TOP2A TOP2B |
| D07866 |
Docetaxel (JAN/INN); Docetaxel (TN); Taxotere (TN) |
(P) unclassified |
| D08080 |
Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18); Insulin Humacart (TN) |
(P) unclassified |
| D08386 |
Pirarubicin hydrochloride; Pinorubin (TN); Therarubicin (TN) |
(P) Target: TOP2A TOP2B |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) unclassified |
| D08914 |
Eribulin mesylate (USAN); Eribulin mesilate (JAN); Halaven (TN) |
(P) unclassified |
| D09197 |
Valsartan and hydrochlorothiazide (JP18); Co-dio (TN) |
(P) unclassified |
| D09727 |
Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) |
(P) unclassified |
| D10526 |
Trifluridine and tipiracil hydrochloride; Lonsurf (TN) |
(P) unclassified |
| D10570 |
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) |
(P) unclassified |
| D10596 |
Pemetrexed sodium hemipentahydrate (JAN); Pemetrexed disodium hemipentahydrate; Pemetrexed accord (TN) |
(P) unclassified |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D11034 |
Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) |
(P) unclassified |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) unclassified |
| D11567 |
Insulin degludec and liraglutide; Xultophy (TN) |
(P) unclassified |
| D11661 |
Bendamustine hydrochloride hydrate (JAN); Bendamustine hydrochloride monohydrate; Treakisym (TN) |
(P) unclassified |
| D11934 |
Pertuzumab, trastuzumab and hyaluronidase; Pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination); Pertuzumab, trastuzumab and hyaluronidase-zzxf; Phesgo (TN) |
(P) unclassified |
| D12353 |
Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN); Xocova (TN) |
(P) unclassified |
